Ulf Mark Schneider (AP)
The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19
Nestlé surprised few this summer when they spent $2.6 billion to buyout Aimmune. The Swiss Butterfingers-and-health conglomerate had long shown more interest in them …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
